Haploidentical transplantation: questions about a related donor
If a transplant team proposes a haploidentical donor pathway, ask it to explain the choice in relation to this patient and the available donors. The important question is not whether a relative wants to help, but how the team has assessed compatibility, donor health and the overall transplant strategy.
What the donor description means
A haploidentical family donor shares one of the inherited HLA sets with the recipient, often described as a half match. A parent, child or some siblings may be considered. This describes tissue matching; it is not a percentage prediction of success. The EBMT handbook explains that donor age, relationship and the transplant approach can matter to selection, so the closest available relative is not automatically the chosen donor.
Request the exact donor relationship and the laboratory findings used to describe the match. Ask the specialist to explain the term “haploidentical” in ordinary language and why this route is being considered instead of another donor option. Do not infer compatibility from a shared surname, blood group or physical resemblance.
The NCI describes HLA assessment as part of donor matching and emphasises individual consideration of transplant benefits and risks. A family relationship does not replace the required laboratory and medical assessment. If testing has already been done, send the full report, including the names and dates needed by the clinical team.
Keep the donor’s assessment separate
The potential donor is also a person needing information, consent and medical evaluation. Ask who will discuss donation with them, who reviews their health and how they can raise concerns privately. A donor should not be treated simply as part of the recipient’s travel booking.
- Which assessments must be completed before donation is confirmed?
- Where will collection occur, and which method is proposed?
- Who explains the donor’s possible effects and recovery arrangements?
- What happens if the donor becomes unwell or cannot proceed?
- Are donor and recipient schedules confirmed or still provisional?
Do not arrange repeated tests independently when the centre has not specified the required method or laboratory.
Clarify the recipient’s full pathway
Ask why the proposed donor route fits the disease situation, how other transplant options were considered and what further information could alter the choice. Request an explanation of the planned monitoring and the support needed after transplantation. The donor label alone cannot predict the patient’s outcome.
If a centre in Turkey is being considered, confirm that it evaluates this specific pathway for the patient’s condition. General transplant services on a website are not confirmation that every donor approach is available for every patient.
Ask about the complete haploidentical programme
The EBMT handbook describes more than one approach to managing immune differences in haploidentical transplantation. Ask which approach the centre proposes and how its experience applies to this disease and age group. The answer should connect donor selection, preparation for transplant and prevention of graft-versus-host disease. Different approaches should not be compared only by the donor-match label.
Ask the specialist to explain the main risks in understandable terms, including failure of the graft to establish blood-cell production, graft-versus-host disease and serious infection. Request the plan for detecting and responding to these problems, and which services are available on site. A quotation or a general transplant count cannot answer how the centre manages this specific pathway.
Keep separate patient and donor appointments and costs. General donor assessment and travel questions are covered in the linked donor guide.
Before any treatment preparation is scheduled, the clinical teams must confirm readiness; the family should not make that decision from this guide. Keep a written record of the proposed donor strategy, what remains unconfirmed and who can answer questions for the donor and recipient separately.
A practical next step
For the practical arrangements, see Finding a stem cell donor: relatives and donor registries.
Sources
Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.